| Rabih Tawk, MD | |
|
4500 San Pablo Rd S, Jacksonville, FL 32224-1865 | |
| (904) 953-2000 | |
| Not Available |
| Full Name | Rabih Tawk |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 24 Years |
| Location | 4500 San Pablo Rd S, Jacksonville, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760613988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | ME107760 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Florida | Jacksonville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic - Florida | 5698689297 | 1310 |
News Archive
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
In hybrid catheterization procedures it is crucial that the imaging system provides the flexibility to quickly and easily access both the patient and ancillary equipment. To form its new hybrid catheterization suite, Miami Children's Hospital, a pioneer in hybrid procedures, recently installed Toshiba America Medical Systems's InfinixTM CF-i bi-plane system with the new CAT-880B hybrid catheterization table.
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.
On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.
To reduce an estimated half million deaths and two million hospitalizations from diarrhea caused by rotavirus each year, the WHO on Friday recommended that oral rotavirus vaccines be added to national childhood immunization programs, broadening access to the vaccine in the developing world, Reuters reports.
› Verified 7 days ago
| Entity Name | Mayo Clinic Jacksonville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790772317 PECOS PAC ID: 5698689297 Enrollment ID: O20031118000388 |
News Archive
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
In hybrid catheterization procedures it is crucial that the imaging system provides the flexibility to quickly and easily access both the patient and ancillary equipment. To form its new hybrid catheterization suite, Miami Children's Hospital, a pioneer in hybrid procedures, recently installed Toshiba America Medical Systems's InfinixTM CF-i bi-plane system with the new CAT-880B hybrid catheterization table.
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.
On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.
To reduce an estimated half million deaths and two million hospitalizations from diarrhea caused by rotavirus each year, the WHO on Friday recommended that oral rotavirus vaccines be added to national childhood immunization programs, broadening access to the vaccine in the developing world, Reuters reports.
› Verified 7 days ago
| Entity Name | University Of Florida Jacksonville Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144276452 PECOS PAC ID: 9133025869 Enrollment ID: O20040128000786 |
News Archive
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
In hybrid catheterization procedures it is crucial that the imaging system provides the flexibility to quickly and easily access both the patient and ancillary equipment. To form its new hybrid catheterization suite, Miami Children's Hospital, a pioneer in hybrid procedures, recently installed Toshiba America Medical Systems's InfinixTM CF-i bi-plane system with the new CAT-880B hybrid catheterization table.
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.
On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.
To reduce an estimated half million deaths and two million hospitalizations from diarrhea caused by rotavirus each year, the WHO on Friday recommended that oral rotavirus vaccines be added to national childhood immunization programs, broadening access to the vaccine in the developing world, Reuters reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rabih Tawk, MD 4500 San Pablo Rd S, Jacksonville, FL 32224-1865 Ph: () - | Rabih Tawk, MD 4500 San Pablo Rd S, Jacksonville, FL 32224-1865 Ph: (904) 953-2000 |
News Archive
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
In hybrid catheterization procedures it is crucial that the imaging system provides the flexibility to quickly and easily access both the patient and ancillary equipment. To form its new hybrid catheterization suite, Miami Children's Hospital, a pioneer in hybrid procedures, recently installed Toshiba America Medical Systems's InfinixTM CF-i bi-plane system with the new CAT-880B hybrid catheterization table.
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.
On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.
To reduce an estimated half million deaths and two million hospitalizations from diarrhea caused by rotavirus each year, the WHO on Friday recommended that oral rotavirus vaccines be added to national childhood immunization programs, broadening access to the vaccine in the developing world, Reuters reports.
› Verified 7 days ago
Dr. Dunbar Alcindor, M.D Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 580 W 8th St, Tower 1 -8th Floor, Jacksonville, FL 32209 Phone: 904-244-9052 | |
Clarence Watridge, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Hector Edward James, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 836 Prudential Dr, Ufjp Neurosurgery - Pediatrics, Jacksonville, FL 32207 Phone: 904-398-5201 Fax: 904-244-3425 | |
Carlos Perez Vega, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Dr. Bernard H. Guiot, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 14810 Old Saint Augustine Rd Ste 207, Jacksonville, FL 32258 Phone: 904-217-7450 Fax: 904-217-7483 | |
Rachel Stein, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Dr. Amos Olabisi Dare, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 544 Cesery Blvd, Suite 310, Jacksonville, FL 32211 Phone: 904-743-9222 Fax: 904-743-9225 |